FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Mann Michael Scott 		2. Issuer Name and Ticker or Trading Symbol

ENDONOVO THERAPEUTICS, INC. [ ENDV ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      __ X __ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
President
(Last)          (First)          (Middle)

6320 CANOGA AVENUE 		3. Date of Earliest Transaction (MM/DD/YYYY)

6/12/2017
(Street)

WOODLAND HILLS, CA 91367
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Common Stock   6/12/2017     P    1000   A $0.057   21180349   D    
Common Stock   6/12/2017     P    1000   A $0.056   21181349   D    
Common Stock   6/12/2017     P    1000   A $0.056   21182349   D    
Common Stock   6/12/2017     P    1000   A $0.056   21183349   D    
Common Stock   6/12/2017     P    1000   A $0.056   21184349   D    
Common Stock   6/12/2017     P    1000   A $0.056   21185349   D    
Common Stock   6/12/2017     P    10000   A $0.056   21195349   D    
Common Stock   6/12/2017     P    1000   A $0.056   21196349   D    
Common Stock   6/12/2017     P    1000   A $0.0558   21197349   D    
Common Stock   6/13/2017     P    1000   A $0.06   21198349   D    
Common Stock   6/13/2017     P    1000   A $0.06   21199349   D    
Common Stock   6/13/2017     P    1000   A $0.0559   21200349   D    
Common Stock   6/13/2017     P    1000   A $0.057   21201349   D    
Common Stock   6/13/2017     P    1000   A $0.058   21202349   D    
Common Stock   6/13/2017     P    1000   A $0.0579   21203349   D    
Common Stock   6/14/2017     P    1000   A $0.059   21204349   D    
Common Stock   6/14/2017     P    1000   A $0.059   21205349   D    
Common Stock   6/14/2017     P    1000   A $0.056   21206349   D    
Common Stock   6/14/2017     P    1000   A $0.056   21207349   D    
Common Stock   6/14/2017     P    1000   A $0.0543   21208349   D    
Common Stock   6/14/2017     P    1000   A $0.0543   21209349   D    
Common Stock   6/14/2017     P    1000   A $0.0538   21210349   D    
Common Stock   6/14/2017     P    1000   A $0.054   21211349   D    
Common Stock   6/14/2017     P    1000   A $0.054   21212349   D    
Common Stock   6/14/2017     P    1000   A $0.054   21213349   D    
Common Stock   6/14/2017     P    1000   A $0.054   21214349   D    
Common Stock   6/14/2017     P    1000   A $0.054   21215349   D    
Common Stock   6/14/2017     P    1000   A $0.054   21216349   D    
Common Stock   6/14/2017     P    1000   A $0.0543   21217349   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares

Explanation of Responses:

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Mann Michael Scott
6320 CANOGA AVENUE
WOODLAND HILLS, CA 91367
X President

Signatures
Michael Mann 6/15/2017
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.